Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Katlama · SciRah

Researcher profile · Semantic Scholar

C. Katlama

Share profile

C. Katlama — researcher profile on SciRah

h-index: 99
Works: 700
Citations: 42K

Most-cited papers

The integrase inhibitors dolutegravir and raltegravir exert pro-adipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes.
Jennifer Gorwood, C. Bourgeois, V. Pourcher, G. Pourcher +13 more
2020Clinical Infectious Diseases139 citations
Semantic Scholar
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
J. Molina, J. Ghosn, L. Assoumou, C. Delaugerre +18 more
2022The Lancet HIV105 citations Open access
Semantic Scholar
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience on behalf of the French CANCERVIH network.
J. Spano, M. Veyri, A. Gobert, A. Guihot +11 more
2019AIDS (London)64 citations Open access
Semantic Scholar
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
M. Lemoine, L. Assoumou, S. De Wit, P. Girard +19 more
2019Journal of Acquired Immune Deficiency Syndromes63 citations Open access
Semantic Scholar
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.
P. Mercié, Julie Arsandaux, C. Katlama, S. Ferret +69 more
2018The Lancet HIV53 citations
Semantic Scholar
Dolutegravir resistance mutations: lessons from monotherapy studies
J. Blanco, A. Marcelin, C. Katlama, E. Martínez
2018Current Opinion in Infectious Diseases45 citations
Semantic Scholar
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
R. Landman, P. de Truchis, L. Assoumou, S. Lambert +18 more
2022The Lancet HIV41 citations Open access
Semantic Scholar
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.
A. Ursenbach, Vincent Max, M. Maurel, F. Bani-Sadr +297 more
2020Journal of Antimicrobial Chemotherapy33 citations
Semantic Scholar
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
B. Abbar, M. Baron, C. Katlama, A. Marcelin +4 more
2020AIDS (London)33 citations Open access
Semantic Scholar
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial
P. de Truchis, L. Assoumou, R. Landman, D. Mathez +53 more
2018Journal of Antimicrobial Chemotherapy33 citations Open access
Semantic Scholar
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
C. Katlama, L. Assoumou, M. Valantin, C. Soulié +14 more
2019Journal of Antimicrobial Chemotherapy32 citations Open access
Semantic Scholar
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V - The LAMRES Study.
M. Santoro, D. Armenia, E. Teyssou, J. R. Santos +10 more
2022Journal of Global Antimicrobial Resistance31 citations Open access
Semantic Scholar
Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up
S. Seang, O. Itani, G. Monsel, B. Abdi +7 more
2022Infectious Diseases Now30 citations Open access
Semantic Scholar
Recurrence and Occurrence of Kaposi's Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia.
R. Palich, M. Veyri, M. Valantin, A. Marcelin +9 more
2020Clinical Infectious Diseases29 citations
Semantic Scholar
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
M. Baron, C. Soulié, A. Lavolé, L. Assoumou +17 more
2022Cells24 citations Open access
Semantic Scholar
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
J. Bastard, C. Couffignal, S. Fellahi, J. Bard +6 more
2019Diabetes & Metabolism24 citations Open access
Semantic Scholar
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
A. Arenas-Pinto, B. Grund, Shweta Sharma, E. Martínez +13 more
2018Clinical Infectious Diseases24 citations Open access
Semantic Scholar
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies.
A. Jary, V. Leducq, N. Désiré, Héloïse Petit +12 more
2020Journal of Infectious Diseases23 citations Open access
Semantic Scholar
Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter prospective study.
M. Lemoine, L. Assoumou, P. Girard, M. Valantin +24 more
2022Clinical Gastroenterology and Hepatology22 citations
Semantic Scholar
A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review
J. Cox, C. Gutner, N. Kronfli, A. Lawson +13 more
2019PLoS ONE21 citations Open access
Semantic Scholar
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1
Judith A. Aberg, Bronagh Shepherd, Marcia Wang, J. Madruga +12 more
2023Infectious Disease and Therapy20 citations Open access
Semantic Scholar
Kinetics of archived M184V mutation in treatment-experienced virally suppressed HIV-infected patients.
R. Palich, E. Teyssou, S. Sayon, B. Abdi +11 more
2021Journal of Infectious Diseases20 citations Open access
Semantic Scholar
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial
J. Bernardino, A. Mocroft, C. Wallet, S. De Wit +11 more
2019PLoS ONE20 citations Open access
Semantic Scholar
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.
S. Grabar, V. Potard, L. Piroth, S. Abgrall +19 more
2023Journal of Antimicrobial Chemotherapy19 citations Open access
Semantic Scholar
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases
A. Jary, V. Leducq, R. Palich, A. Gothland +14 more
2018Journal of Clinical Microbiology19 citations Open access
Semantic Scholar
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
C. Charpentier, A. Storto, C. Soulié, V. Ferré +12 more
2021Journal of Antimicrobial Chemotherapy18 citations
Semantic Scholar
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
V. Vieillard, B. Combadière, R. Tubiana, O. Launay +18 more
2019npj Vaccines18 citations Open access
Semantic Scholar
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance
I. Malet, F. Ambrosio, F. Subra, Béatrice Herrmann +12 more
2018Journal of Antimicrobial Chemotherapy18 citations Open access
Semantic Scholar
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)
H. Melliez, M. Mary-Krause, L. Bocket, M. Guiguet +15 more
2018Clinical Infectious Diseases18 citations
Semantic Scholar
Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older
C. Allavena, H. Blain, Xian Abulizi, L. Slama +7 more
2022AIDS (London)17 citations
Semantic Scholar
Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART
R. Palich, R. Tubiana, B. Abdi, Fouzi Mestari +5 more
2018Journal of Antimicrobial Chemotherapy17 citations Open access
Semantic Scholar
Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.
Abiu Sempere, L. Assoumou, A. González-Cordón, L. Waters +20 more
2023Clinical Infectious Diseases16 citations
Semantic Scholar
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
S. Raymond, F. Nicot, C. Pallier, Pantxika Bellecave +171 more
2018Clinical Infectious Diseases16 citations Open access
Semantic Scholar
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
B. Sellem, B. Abdi, M. Lê, R. Tubiana +10 more
2023Journal of Personalized Medicine14 citations Open access
Semantic Scholar
High uptake of vaccination against mpox in men who have sex with men (MSM) on HIV pre-exposure prophylaxis (PrEP) in Paris, France
R. Palich, Thibaut Jedrzejewski, L. Schneider, N. Qatib +6 more
2023Sexually Transmitted Infections14 citations Open access
Semantic Scholar
Low Immune Response Rate of HIV-Infected Patients to a Single Injection of Hepatitis A Vaccine.
Lucie Noel, R. Tubiana, A. Simon, M. Valantin +6 more
2020Médecine et maladies infectieuses14 citations Open access
Semantic Scholar
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
L. Waters, L. Assoumou, A. González-Cordón, S. Rusconi +19 more
2022Clinical Infectious Diseases13 citations Open access
Semantic Scholar
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
D. Costagliola, V. Potard, S. Lang, N. de Castro +14 more
2019Journal of Infectious Diseases13 citations
Semantic Scholar
Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine.
L. Assoumou, C. Racine, S. Fellahi, A. Lamazière +8 more
2020AIDS (London)12 citations Open access
Semantic Scholar
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
I. Poizot-Martin, V. Obry-Roguet, C. Duvivier, C. Lions +288 more
2020Journal of the European Academy of Dermatology and Venereology11 citations Open access
Semantic Scholar
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
L. Castain, Marine Perrier, C. Charpentier, R. Palich +13 more
2019Journal of Antimicrobial Chemotherapy11 citations Open access
Semantic Scholar
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
S. Lambert-Niclot, A. Boyd, Djeneba B. Fofana, N. Valin +10 more
2019Open Forum Infectious Diseases11 citations Open access
Semantic Scholar
Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients
A. Fayçal, A. Ndoadoumgue, B. Sellem, C. Blanc +18 more
2021Infectious Diseases Now10 citations Open access
Semantic Scholar
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
C. Charpentier, G. Peytavin, F. Raffi, C. Burdet +10 more
2020Journal of Antimicrobial Chemotherapy10 citations Open access
Semantic Scholar
No HIV-1 molecular evolution on long term antiretroviral therapy initiated during primary HIV-1 infection.
B. Abdi, Thuy Nguyen, S. Brouillet, N. Désiré +13 more
2020AIDS (London)10 citations
Semantic Scholar
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
E. Lathouwers, E. Y. Wong, K. Brown, B. Baugh +159 more
2019AIDS Research and Human Retroviruses10 citations Open access
Semantic Scholar
Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens
R. Batterham, N. Espinosa, C. Katlama, M. McKellar +9 more
2023Open Forum Infectious Diseases9 citations Open access
Semantic Scholar
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children
Djeneba B. Fofana, Houdou Diarra, Ibrehima Guindo, M. Savadogo +17 more
2023Viruses9 citations Open access
Semantic Scholar
Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc
J. Bastard, V. Pelloux, R. Alili, S. Fellahi +8 more
2021AIDS (London)9 citations Open access
Semantic Scholar
Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
B. Tan, M. Chalouni, D. Ceron, A. Cinaud +34 more
2020Clinical Infectious Diseases9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Marcelin×19
Invite
A. Marcelin — researcher profile on SciRah
M. Valantin×15
Invite
M. Valantin — researcher profile on SciRah
L. Assoumou×14
Invite
L. Assoumou — researcher profile on SciRah
D. Costagliola×13
Invite
D. Costagliola — researcher profile on SciRah

×12

Invite

F. Raffi — researcher profile on SciRah

Invite

V. Cálvez — researcher profile on SciRah

Invite

R. Palich — researcher profile on SciRah

Invite

D. Descamps — researcher profile on SciRah

Invite

J. Capeau — researcher profile on SciRah

I. Poizot-Martin×8

Invite

I. Poizot-Martin — researcher profile on SciRah

Invite

R. Landman — researcher profile on SciRah

Invite

V. Joly — researcher profile on SciRah